Written by Clinic Director, Ashok Gupta
I believe Unexplained Pain Syndromes and ME/CFS are conditions that have the same underlying cause. The good news is that it is possible to recover from pain syndromes, and we have had many people who have recovered using The Gupta Program.
In a recent published study on ME/CFS & Fibromyalgia, over 90% of participants reported improvements, and two-thirds reached a full 80-100% recovery.
What May Cause Chronic Pain Syndromes?
We believe that chronic unexplained pain syndromes may ultimately be being caused by abnormalities in the brain, specifically around two brain structures, the “Amygdala” and the “Insula”.
The Amygdala is the part of our brain that is responsible for the “fight or flight” response, or the stress response. It is also known as the response of the sympathetic nervous system to threats. The insula may be responsible for conditioned immune system responses. From our published research which you can view here, it seems that these parts of the brain gets stuck in a chronic state of hyper-arousal, quickly using up all the body’s store of energy, as well as causing chronic localized and generalized inflammation, causing pain. It also causes lots of secondary issues which contribute to a whole host of symptoms in the body such as brain fog, difficulty concentrating, muscle pain, and exhaustion.
How Can I Recover From the Condition?
Our highly successful and well known international Workshops, Home Study course and Webinar series, have helped hundreds of people all over the world recover from pain syndromes. The treatment involves a series of brain retraining exercises designed to “retrain the Amygdala & Insula” and other parts of the brain that are stuck in a state of hyper-arousal. The brain is not fixed in its responses, it can be rewired. Neuroscientists call this “Neuroplasticity” and it is one of the hottest topics in science at the moment. We are currently pursuing various research avenues to conduct a large randomised trial to finally prove the powerful effects of this treatment. In a recent study, over 90% of participants reported improvements, and two-thirds reached a full recovery.